Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Unlock the editor’s digestion free
FT editor Roula Khalaf, chooses his favorite stories in this weekly newsletter.
Isomorphic laboratories, Google’s Deepmind Artificial Intelligence Unit, $ 600 million in the first foreign financing period, won $ 600 million to bet the AI’s “disease”.
CEO Nobel Prize, GÜNAL Demis Hassabis, the CEO of London, the largest supporter of the ChatQPT manufacturer Openai was headed by an investor in New York.
The tour was announced on Monday, as well as Google’s Mother’s company Alphobs Capital GEA participated in GV. He also included additional investment from the alphabet.
Financial details were not discovered as an appraisal of isomorphic laboratories and a new property structure. However, the alphabet remains as most shareholders.
Fundraising is the largest in which a British is the largest, yet financial impetus for AI company Jabber By the end of the year, there are drugs prepared by clinical trials by the end of the year.
“This financing will further develop the development of our use of our medicinal design, and helps our programs to develop clinical development, and with the help of the AI, the solution of all diseases is focused on our mission,” he said.
The company will help the development of investment, AI research and development and will allow the company to expand the team.
“We believe that Isomorphic pharmacy has become a rare position to determine a new century of the discovery and design of the design, and we are inspired by their mission and the extraordinary progress from the emergency.”
Isomorf Laboratories Jumped Depth In 2021 and since today, Novartis and Eli Lilly, those with large pharmaceutical companies, are interested in reducing costs and developing the effects faster.
In May last year, Deepmind, the Ligans, which connect and significant diseases, as well as the structures of the genetic code code, as well as a EU model, which can predict Ligands. Researchers of Isomorphic laboratories use the tool and the owner of the owner of owner to manage the forecasts and simulating drug development.
In the first year of full transactions in 2023 this The prejudices reported Before the first pound of £ 17 million before £ 60 million, according to the latest accounts given at the companies home. Isomorphic laboratories, as well as R & D, increased by £ 129 million, and the value of employees has reached £ 20 million with 71 titles.
In October last year, the Nobel Prize, which developed the structure of proteins, which developed last October last October, “Improving the structure of proteins,” Today marks a big step for a new period of a new drug discovery. “
